218 related articles for article (PubMed ID: 11723800)
1. Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors.
Cecic I; Parkins CS; Korbelik M
Photochem Photobiol; 2001 Nov; 74(5):712-20. PubMed ID: 11723800
[TBL] [Abstract][Full Text] [Related]
2. Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy.
Cecic I; Stott B; Korbelik M
Int Immunopharmacol; 2006 Aug; 6(8):1259-66. PubMed ID: 16782538
[TBL] [Abstract][Full Text] [Related]
3. Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors.
Cecic I; Korbelik M
Cancer Lett; 2002 Sep; 183(1):43-51. PubMed ID: 12049813
[TBL] [Abstract][Full Text] [Related]
4. The value of serum alpha-N-acetylgalactosaminidase measurement for the assessment of tumour response to radio- and photodynamic therapy.
Korbelik M; Naraparaju VR; Yamamoto N
Br J Cancer; 1998 Mar; 77(6):1009-14. PubMed ID: 9528849
[TBL] [Abstract][Full Text] [Related]
5. Enzyme-activatable imaging probe reveals enhanced neutrophil elastase activity in tumors following photodynamic therapy.
Mitra S; Modi KD; Foster TH
J Biomed Opt; 2013 Oct; 18(10):101314. PubMed ID: 23897439
[TBL] [Abstract][Full Text] [Related]
6. Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors.
Korbelik M; Sun J; Posakony JJ
Photochem Photobiol; 2001 Apr; 73(4):403-9. PubMed ID: 11332036
[TBL] [Abstract][Full Text] [Related]
7. Pro-apoptotic and anti-inflammatory properties of the green tea constituent epigallocatechin gallate increase photodynamic therapy responsiveness.
Ferrario A; Luna M; Rucker N; Wong S; Gomer CJ
Lasers Surg Med; 2011 Sep; 43(7):644-50. PubMed ID: 22057492
[TBL] [Abstract][Full Text] [Related]
8. Role of cytokines in photodynamic therapy-induced local and systemic inflammation.
Gollnick SO; Evans SS; Baumann H; Owczarczak B; Maier P; Vaughan L; Wang WC; Unger E; Henderson BW
Br J Cancer; 2003 Jun; 88(11):1772-9. PubMed ID: 12771994
[TBL] [Abstract][Full Text] [Related]
9. Complement activation cascade and its regulation: relevance for the response of solid tumors to photodynamic therapy.
Korbelik M; Cecic I
J Photochem Photobiol B; 2008 Oct; 93(1):53-9. PubMed ID: 18715798
[TBL] [Abstract][Full Text] [Related]
10. The characterization of blood flow changes in mouse tumor during Photofrin-based photodynamic therapy by using the color Doppler ultrasonography.
Dubreta K; Ivankovic S; Lovrencic-Huzjan A; Bosnar-Puretic M; Stojkovic R; Jurin M
Oncol Rep; 2009 Nov; 22(5):1253-7. PubMed ID: 19787247
[TBL] [Abstract][Full Text] [Related]
11. Hyperoxygenation enhances the tumor cell killing of photofrin-mediated photodynamic therapy.
Huang Z; Chen Q; Shakil A; Chen H; Beckers J; Shapiro H; Hetzel FW
Photochem Photobiol; 2003 Nov; 78(5):496-502. PubMed ID: 14653582
[TBL] [Abstract][Full Text] [Related]
12. High-resolution PET imaging for in vivo monitoring of tumor response after photodynamic therapy in mice.
Lapointe D; Brasseur N; Cadorette J; La Madeleine C; Rodrigue S; van Lier JE; Lecomte R
J Nucl Med; 1999 May; 40(5):876-82. PubMed ID: 10319764
[TBL] [Abstract][Full Text] [Related]
13. Luminol Chemiluminescence Reports Photodynamic Therapy-Generated Neutrophil Activity In Vivo and Serves as a Biomarker of Therapeutic Efficacy.
Davis RW; Snyder E; Miller J; Carter S; Houser C; Klampatsa A; Albelda SM; Cengel KA; Busch TM
Photochem Photobiol; 2019 Jan; 95(1):430-438. PubMed ID: 30357853
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcome of Photofrin-based photodynamic therapy for T1 and T2 oral squamous cell carcinoma and dysplasia.
Ikeda H; Tobita T; Ohba S; Uehara M; Asahina I
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):229-35. PubMed ID: 23993848
[TBL] [Abstract][Full Text] [Related]
15. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
16. Irradiance controls photodynamic efficacy and tissue heating in experimental tumours: implication for interstitial PDT of locally advanced cancer.
Shafirstein G; Bellnier DA; Oakley E; Hamilton S; Habitzruther M; Tworek L; Hutson A; Spernyak JA; Sexton S; Curtin L; Turowski SG; Arshad H; Henderson B
Br J Cancer; 2018 Nov; 119(10):1191-1199. PubMed ID: 30353043
[TBL] [Abstract][Full Text] [Related]
17. Neutrophils as inflammatory and immune effectors in photodynamic therapy-treated mouse SCCVII tumours.
Sun J; Cecic I; Parkins CS; Korbelik M
Photochem Photobiol Sci; 2002 Sep; 1(9):690-5. PubMed ID: 12665307
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ
Cancer Res; 2000 Aug; 60(15):4066-9. PubMed ID: 10945611
[TBL] [Abstract][Full Text] [Related]
19. IL-6 potentiates tumor resistance to photodynamic therapy (PDT).
Brackett CM; Owczarczak B; Ramsey K; Maier PG; Gollnick SO
Lasers Surg Med; 2011 Sep; 43(7):676-85. PubMed ID: 22057495
[TBL] [Abstract][Full Text] [Related]
20. Tumor response to mTHPC-mediated photodynamic therapy exhibits strong correlation with extracellular release of HSP70.
Mitra S; Giesselman BR; De Jesús-Andino FJ; Foster TH
Lasers Surg Med; 2011 Sep; 43(7):632-43. PubMed ID: 22057491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
